4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with Diathesis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvord, WG; Bode, C; Kinjo, T; Klinman, DM | 1 |
| Hayashi, N; Hiratsuka, A; Ishihara, Y; Kakurai, N; Kuriyama, A; Miyamoto, C; Nishiyama, T; Ogura, K; Ohnuma, T; Yanagita, H | 1 |
| Avanzo, JL; Dagli, ML; Fukumasu, H; Mennecier, G; Mori, CM; Sanches, DS | 1 |
| Linnoila, RI; Mukherjee, AB; Yang, Y; Zhang, Z | 1 |
| Dacic, S; Land, SR; Lyker, JS; Siegfried, JM; Stabile, LP; Zamboni, BA | 1 |
| Razani-Boroujerdi, S; Sopori, ML | 1 |
| Hoffmann, D; Wynder, EL | 1 |
| Castonguay, A; Rioux, N | 1 |
| Belinsky, SA; March, TH; Wardlaw, SA | 1 |
9 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Diathesis
| Article | Year |
|---|---|
Suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Disease Models, Animal; Disease Susceptibility; Female; Gene Expression; Humans; Interleukin-1beta; Lung Neoplasms; Mice; Nitrosamines; Oligodeoxyribonucleotides; Pneumonia; RNA, Messenger; Silicon Dioxide; Silicosis | 2014 |
Formation and stability of 4-(hydroxymethylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronide, a stable form of reactive intermediate produced from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, in mice.
Topics: Animals; Carcinogenesis; Disease Susceptibility; Hydrogen-Ion Concentration; Liver; Male; Mice, Inbred C57BL; Mice, Inbred Strains; Nitrosamines; Tissue Distribution | 2014 |
Higher susceptibility of spontaneous and NNK-induced lung neoplasms in connexin 43 deficient CD1 × AJ F1 mice: paradoxical expression of connexin 43 during lung carcinogenesis.
Topics: Animals; beta Catenin; Blotting, Western; Carcinogens; Cell Transformation, Neoplastic; Connexin 43; Disease Susceptibility; Female; Immunoenzyme Techniques; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitrosamines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2013 |
Increased susceptibility of mice lacking Clara cell 10-kDa protein to lung tumorigenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a potent carcinogen in cigarette smoke.
Topics: Adenoma; Animals; Carcinogens; Cell Transformation, Neoplastic; Disease Susceptibility; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Fas Ligand Protein; Humans; Lung; Lung Neoplasms; MAP Kinase Signaling System; Membrane Glycoproteins; Mice; Mice, Knockout; Nitrosamines; Smoking; Tobacco Smoke Pollution; Uteroglobin | 2004 |
Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Animals; Carcinogens; Disease Susceptibility; Epithelium; Female; Hepatocyte Growth Factor; Humans; Lung; Lung Neoplasms; Male; Mice; Mice, Transgenic; Nitrosamines; Respiratory Mucosa | 2006 |
Early manifestations of NNK-induced lung cancer: role of lung immunity in tumor susceptibility.
Topics: ADP-ribosyl Cyclase 1; alpha7 Nicotinic Acetylcholine Receptor; Animals; Calcium; CD3 Complex; Cell Proliferation; Cyclooxygenase 2; Disease Susceptibility; Erythrocytes; Immunization; Lung; Lung Neoplasms; Lymph Nodes; Mice; Nitrosamines; Receptors, Nicotinic; Species Specificity; Spleen; T-Lymphocytes | 2007 |
Smoking and lung cancer: scientific challenges and opportunities.
Topics: Adenocarcinoma; Black or African American; Black People; Carcinoma, Squamous Cell; Disease Susceptibility; Female; Humans; Incidence; Japan; Lung Neoplasms; Male; Nitrosamines; Risk Factors; Sex Factors; Smoking; Tobacco Smoke Pollution; United Kingdom; United States; White People | 1994 |
Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Carcinogens; Cyclooxygenase Inhibitors; Diet; Dinoprostone; Disease Susceptibility; Drug Administration Schedule; Female; Hemolytic Plaque Technique; Immunosuppressive Agents; Lung Neoplasms; Mice; Mice, Inbred A; Nicotiana; Nitrosamines; Plants, Toxic; Smoke; Stomach Neoplasms; Sulindac | 1997 |
Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinogens; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Susceptibility; Humans; Isoenzymes; Lung Neoplasms; Membrane Proteins; Mice; Mice, Inbred A; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Nitrosamines; Precancerous Conditions; Proline; Prostaglandin-Endoperoxide Synthases; Pulmonary Alveoli; Pyrazoles; RNA, Messenger; Sulfonamides; Thiocarbamates; Transcription, Genetic; Transplantation, Heterologous; Tumor Cells, Cultured | 2000 |